Cargando…
Combination Therapy of Plasma Exchange and Rituximab to Treat Cicatricial Pemphigoid and Bullous Pemphigoid
The pemphigoid group of subepidermal autoimmune blistering diseases can affect both cutaneous and mucosal tissues. Therapy of this group of diseases, including cicatricial pemphigoid (CP) and bullous pemphigoid (BP), consists of systemic steroids and immunomodulatory agents. Recalcitrant cases have...
Autores principales: | Kunadia, Anuj, Sami, Naveed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713951/ https://www.ncbi.nlm.nih.gov/pubmed/34984113 http://dx.doi.org/10.7759/cureus.19932 |
Ejemplares similares
-
When Bullous Pemphigoid Is Not Bullous Pemphigoid: The Importance of Going Beyond Direct Immunofluorescence
por: Hopkins, Christina R, et al.
Publicado: (2022) -
Delayed Onset of Bullous Pemphigoid Secondary to Nivolumab
por: Olsen, Eric, et al.
Publicado: (2023) -
A Case of Bullous Pemphigoid Associated With Nivolumab Therapy
por: Gotera, Nico, et al.
Publicado: (2022) -
Dyshidrosiform Bullous Pemphigoid: Case Reports and Review
por: Cohen, Philip R
Publicado: (2020) -
Hydrochlorothiazide vs Venlafaxine: Drug-induced Bullous Pemphigoid
por: Naramala, Srikanth, et al.
Publicado: (2019)